Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, An Issue of Rheumatic Disease Clinics, 1st Edition
Author :
By Kenneth J. Scalapino, MD and Charles R. Thomas JR, MD
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics cov
...view more
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.
This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.
Author Information
By Kenneth J. Scalapino, MD, Section Chief, Rheumatology
Hospital Road
Portland, OR and Charles R. Thomas JR, MD, Professor & Chairman, Dept. of Radiation Medicine, Oregon Health and Sciences University Knight Cancer Institute, Portland Oregon
By Kenneth J. Scalapino, MD, Section Chief, Rheumatology
Hospital Road
Portland, OR and Charles R. Thomas JR, MD, Professor & Chairman, Dept. of Radiation Medicine, Oregon Health and Sciences University Knight Cancer Institute, Portland Oregon
https://www.asia.elsevierhealth.com/paraneoplastic-and-cancer-treatment-related-rheumatic-disorders-an-issue-of-rheumatic-disease-clinics-9781455711895.html299963Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, An Issue of Rheumatic Disease Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9781455711895_7.jpg89.0998.99USDInStock/Medicine & Surgery/Rheumatology/Clinics/Medicine/Rheumatology/Clinics/Clinics/Medicine/Rheumatology/Japan Titles43350904388725505455550546665255041525983552631601418269243350884886536505455351451205259833This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes. This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.00add-to-cart97814557118952011 and earlierProfessionalBy Kenneth J. Scalapino, MD and Charles R. Thomas JR, MD20111Book152w x 229h (6.00" x 9.00")Saunders0Dec 13, 2011IN STOCKBy <STRONG>Kenneth J. Scalapino</STRONG>, MD, Section Chief, Rheumatology
Hospital Road
Portland, OR and <STRONG>Charles R. Thomas JR</STRONG>, MD, Professor & Chairman, Dept. of Radiation Medicine, Oregon Health and Sciences University Knight Cancer Institute, Portland OregonClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select